+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type; By End-Use; By Source; By Regions; Segment Forecast, 2021 - 2028

  • PDF Icon

    Report

  • 112 Pages
  • April 2021
  • Region: Global
  • Polaris Market Research
  • ID: 5322010
Description Jump to:
The global primary cells market size is expected to reach USD 1.79 billion by 2028 according to this new study. The report “Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type (Hematopoietic, Hepatocytes, Renal, Gastrointestinal, Skin, Lung); By End-Use (Medical, Pharmaceutical & Biotechnology Companies, Research Institutes); By Source; By Regions; Segment Forecast, 2021-2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing investments in biomedical research coupled with growth in the occurrence of diseases such as cancer drive the growth of the primary cell culture market. Increasing demand for advanced drug development and testing, growing applications in genetic engineering and virology, and stringent regulations regarding animal testing boost the growth of this market.

The significant growth in healthcare and pharmaceutical sectors, technological advancements, and growing use of primary cells in stem cell therapy are some factors expected to provide growth opportunities during the forecast period. The different types of primary cells include hematopoietic, hepatocytes, renal cells, gastrointestinal cells, skin cells, lung cells, and others. There has been a high demand for hematopoietic cells, which are derived from blood and bone marrow.

The demand for human primary cells was high in 2019. Human primary cells exhibit the functional and morphological characteristics of their tissue of origin. Human primary cells are increasingly being used in cancer research, and drug discovery. Other applications driving the growth of this segment include 3D cell culture, drug screening, and toxicity testing, monoclonal antibodies, and genetic engineering.

The increasing use of these cells for treatment and research associated with cancer, coupled with technological advancements drives the market growth. Hematopoietic primary cells are increasingly being used in stem cell therapy, vaccine development, and the study of tissue and organ replacement, thereby boosting the growth of this segment.

The demand for primary cells has increased from pharmaceutical and biotechnology companies for applications such as research and development, drug discovery, testing of new drugs, cosmetics, and chemicals, and analyzing of maximum permissible dosage of new drugs. The increasing investments in biomedical research, coupled with government initiatives support the growth of this segment.

North America dominated the global primary cell culture market in 2020 and is expected to maintain its dominance over the forecast period. Growing advancements in cancer research, significant investment in healthcare services, and the increasing occurrence of cancer-related disorders support market growth in this region. The increasing geriatric population coupled with government initiatives and programs, and emerging healthcare and pharmaceutical sectors fuel growth in this region.

Some major market participants include Cell Biologics, Inc, ZenBio, Inc, Stem Cell Technologies, Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Cell Applications, Inc, Pelobiotech, Merck KGaA, Axol Bioscience Ltd, Promocell, ALLCells, Lonza Group, AG, and Creative Bioarray.

The publisher has segmented the primary cells market report on the basis of source, type, end-use, and region:


Primary Cells Source Outlook (Revenue, USD Million, 2016-2028)


  • Animal Primary Cells
  • Human Primary Cells

Primary Cells Type Outlook (Revenue, USD Million, 2016-2028)


  • Hematopoietic
  • Hepatocytes
  • Renal Cells
  • Gastrointestinal Cells
  • Skin Cells
  • Lung Cells
  • Others

Primary Cells End-Use Outlook (Revenue, USD Million, 2016-2028)


  • Medical
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Others

Primary Cells Regional Outlook (Revenue, USD Million, 2016-2028)


  • North America
  • U.S
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Colombia
  • RoLATAM
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • UAE
  • RoMEA
Frequently Asked Questions about the Primary Cells Market

What is the estimated value of the Primary Cells Market?

The Primary Cells Market was estimated to be valued at $955 Million in 2021.

What is the growth rate of the Primary Cells Market?

The growth rate of the Primary Cells Market is 8.4%, with an estimated value of $1790 Million by 2028.

What is the forecasted size of the Primary Cells Market?

The Primary Cells Market is estimated to be worth $1790 Million by 2028.

Who are the key companies in the Primary Cells Market?

Key companies in the Primary Cells Market include Cell Biologics Inc., ZenBio Inc., Stem Cell Technologies, Sigma, Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Cell Applications Inc. and Pelobiotech.
Report AttributeDetails
No. of Pages112
PublishedApril 2021
Forecast Period2021 - 2028
Estimated Market Value ( USD ) in 2021 $ 955 Million
Forecasted Market Value ( USD ) by 2028 $ 1790 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned16

Table of Contents

1. Chapter 1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Chapter 2. Executive Summary
2.1. Market Highlights
3. Chapter 3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Chapter 4. Primary Cells Market Insights
4.1. Primary Cells - Industry snapshot
4.2. Primary Cells Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Threats of New Entrants
4.3.3. Bargaining Power of Buyers
4.3.4. Threats of Substitute
4.3.5. Rivalry among existing firms
4.4. Primary Cells Market PESTLE Analysis
4.5. Value Chain Analysis
4.6. Competitive Ranking Analysis, 2020
5. Chapter 5. Primary Cells Market Assessment by Source
5.1. Introduction
5.1.1. Global Primary Cells Market Share, By Source, 2020 & 2028
5.2. Animal Primary Cells
5.2.1. Global Primary Cells Market, by Animal Primary Cells, 2016-2028 (USD Million)
5.2.2. Global Primary Cells Market, by Animal Primary Cells, by Region, 2016-2028 (USD Million)
5.3. Human Primary Cells
5.3.1. Global Primary Cells Market, by Human Primary Cells, 2016-2028 (USD Million)
5.3.2. Global Primary Cells Market, by Human Primary Cells, by Region, 2016-2028 (USD Million)
6. Chapter 6. Primary Cells Market Assessment by Type
6.1. Introduction
6.1.1. Global Primary Cells Market Share, By Type, 2020 & 2028
6.2. Hematopoietic
6.2.1. Global Primary Cells Market, by Hematopoietic, 2016-2028 (USD Million)
6.2.2. Global Primary Cells Market, by Hematopoietic, by Region, 2016-2028 (USD Million)
6.3. Hepatocytes
6.3.1. Global Primary Cells Market, by Hepatocytes, 2016-2028 (USD Million)
6.3.2. Global Primary Cells Market, by Hepatocytes, by Region, 2016-2028 (USD Million)
6.4. Renal Cells
6.4.1. Global Primary Cells Market, by Renal Cells, 2016-2028 (USD Million)
6.4.2. Global Primary Cells Market, by Renal Cells, by Region, 2016-2028 (USD Million)
6.5. Gastrointestinal Cells
6.5.1. Global Primary Cells Market, by Gastrointestinal Cells, 2016-2028 (USD Million)
6.5.2. Global Primary Cells Market, by Gastrointestinal Cells, by Region, 2016-2028 (USD Million)
6.6. Skin Cells
6.6.1. Global Primary Cells Market, by Skin Cells, 2016-2028 (USD Million)
6.6.2. Global Primary Cells Market, by Skin Cells, by Region, 2016-2028 (USD Million)
6.7. Lung Cells
6.7.1. Global Primary Cells Market, by Lung Cells, 2016-2028 (USD Million)
6.7.2. Global Primary Cells Market, by Lung Cells, by Region, 2016-2028 (USD Million)
6.8. Others
6.8.1. Global Primary Cells Market, by Others, 2016-2028 (USD Million)
6.8.2. Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
7. Chapter 7. Primary Cells Market Assessment by End-User
7.1. Introduction
7.1.1. Global Primary Cells Market Share, By End-User, 2020 & 2028
7.2. Medical
7.2.1. Global Primary Cells Market, by Medical, 2016-2028 (USD Million)
7.2.2. Global Primary Cells Market, by Medical, by Region, 2016-2028 (USD Million)
7.3. Pharmaceutical and Biotechnology Companies
7.3.1. Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, 2016-2028 (USD Million)
7.3.2. Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, by Region, 2016-2028 (USD Million)
7.4. Research Institutes
7.4.1. Global Primary Cells Market, by Research Institutes, 2016-2028 (USD Million)
7.4.2. Global Primary Cells Market, by Research Institutes, by Region, 2016-2028 (USD Million)
7.5. Others
7.5.1. Global Primary Cells Market, by Others, 2016-2028 (USD Million)
7.5.2. Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
8. Chapter 8. Primary Cells Market Assessment by Geography
8.1. Introduction
8.1.1. Global Primary Cells Market Share, By Geography, 2020 & 2028.
8.2. Primary Cells Market - North America
8.2.1. North America: Primary Cells Market, by Country, 2016-2028 (USD Million)
8.2.2. North America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.2.3. North America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.2.4. North America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.2.5. Primary Cells Market - U. S.
8.2.5.1. U. S.: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.2.5.2. U. S.: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.2.5.3. U. S.: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.2.6. Primary Cells Market - Canada
8.2.6.1. Canada: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.2.6.2. Canada: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.2.6.3. Canada: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.3. Primary Cells Market - Europe
8.3.1. Europe: Primary Cells Market, by Country, 2016-2028 (USD Million)
8.3.2. Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.3.3. Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.3.4. Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.3.5. Primary Cells Market - Germany
8.3.5.1. Germany: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.3.5.2. Germany: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.3.5.3. Germany: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.3.6. Primary Cells Market - UK
8.3.6.1. UK: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.3.6.2. UK: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.3.6.3. UK: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.3.7. Primary Cells Market - France
8.3.7.1. France: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.3.7.2. France: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.3.7.3. France: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.3.8. Primary Cells Market - Italy
8.3.8.1. Italy: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.3.8.2. Italy: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.3.8.3. Italy: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.3.9. Primary Cells Market - Spain
8.3.9.1. Spain: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.3.9.2. Spain: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.3.9.3. Spain: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.3.10. Primary Cells Market - Rest of Europe
8.3.10.1. Rest of Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.3.10.2. Rest of Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.3.10.3. Rest of Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.4. Primary Cells Market - Asia-Pacific
8.4.1. Asia Pacific: Primary Cells Market, by Country, 2016-2028 (USD Million)
8.4.2. Asia-Pacific: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.4.3. Asia-Pacific: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.4.4. Asia-Pacific: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.4.5. Primary Cells Market - China
8.4.5.1. China: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.4.5.2. China: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.4.5.3. China: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.4.6. Primary Cells Market - India
8.4.6.1. India: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.4.6.2. India: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.4.6.3. India: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.4.7. Primary Cells Market - Japan
8.4.7.1. Japan: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.4.7.2. Japan: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.4.7.3. Japan: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.4.8. Primary Cells Market - South Korea
8.4.8.1. South Korea: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.4.8.2. South Korea: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.4.8.3. South Korea: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.4.9. Primary Cells Market - Rest of APAC
8.4.9.1. Rest of APAC: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.4.9.2. Rest of APAC: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.4.9.3. Rest of APAC: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.5. Primary Cells Market - Latin America
8.5.1. Latin America: Primary Cells Market, by Country, 2016-2028 (USD Million)
8.5.2. Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.5.3. Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.5.4. Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.5.5. Primary Cells Market - Brazil
8.5.5.1. Brazil: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.5.5.2. Brazil: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.5.5.3. Brazil: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.5.6. Primary Cells Market - Mexico
8.5.6.1. Mexico: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.5.6.2. Mexico: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.5.6.3. Mexico: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.5.7. Primary Cells Market - Colombia
8.5.7.1. Colombia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.5.7.2. Colombia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.5.7.3. Colombia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.5.8. Primary Cells Market - Rest of Latin America
8.5.8.1. Rest of Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.5.8.2. Rest of Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.5.8.3. Rest of Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.6. Primary Cells Market - Middle East and Africa
8.6.1. Middle East & Africa: Primary Cells Market, by Country, 2016-2028 (USD Million)
8.6.2. Middle East & Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.6.3. Middle East & Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.6.4. Middle East & Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.6.5. Primary Cells Market - Saudi Arabia
8.6.5.1. Saudi Arabia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.6.5.2. Saudi Arabia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.6.5.3. Saudi Arabia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.6.6. Primary Cells Market - South Africa
8.6.6.1. South Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.6.6.2. South Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.6.6.3. South Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.6.7. Primary Cells Market - Israel
8.6.7.1. Israel: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.6.7.2. Israel: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.6.7.3. Israel: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.6.8. Primary Cells Market - UAE
8.6.8.1. UAE: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.6.8.2. UAE: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.6.8.3. UAE: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
8.6.9. Primary Cells Market - Rest of MEA
8.6.9.1. Rest of MEA: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
8.6.9.2. Rest of MEA: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
8.6.9.3. Rest of MEA: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
9. Chapter 9. Competitive Landscape
9.1. Expansion and Product Launch Analysis
9.1.1. Expansion
9.1.2. Product Launch
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Chapter 10. Company Profiles
10.1. Cell Biologics, Inc.
10.1.1. Business Overview
10.1.2. Financial Snapshot
10.1.3. Products and Services Benchmarking
10.1.4. Recent Development
10.2. ZenBio, Inc.
10.2.1. Business Overview
10.2.2. Financial Snapshot
10.2.3. Products and Services Benchmarking
10.2.4. Recent Development
10.3. Stem Cell Technologies
10.3.1. Business Overview
10.3.2. Financial Snapshot
10.3.3. Products and Services Benchmarking
10.3.4. Recent Development
10.4. Sigma-Aldrich
10.4.1. Business Overview
10.4.2. Financial Snapshot
10.4.3. Products and Services Benchmarking
10.4.4. Recent Development
10.5. Thermo Fisher Scientific
10.5.1. Business Overview
10.5.2. Financial Snapshot
10.5.3. Products and Services Benchmarking
10.5.4. Recent Development
10.6. Cureline
10.6.1. Business Overview
10.6.2. Financial Snapshot
10.6.3. Products and Services Benchmarking
10.6.4. Recent Development
10.7. American Type Culture Collection
10.7.1. Business Overview
10.7.2. Financial Snapshot
10.7.3. Products and Services Benchmarking
10.7.4. Recent Development
10.8. Cell Applications, Inc.
10.8.1. Business Overview
10.8.2. Financial Snapshot
10.8.3. Products and Services Benchmarking
10.8.4. Recent Development
10.9. Pelobiotech
10.9.1. Business Overview
10.9.2. Financial Snapshot
10.9.3. Products and Services Benchmarking
10.9.4. Recent Development
10.10. Merck KGaA
10.10.1. Business Overview
10.10.2. Financial Snapshot
10.10.3. Products and Services Benchmarking
10.10.4. Recent Development
10.11. Axol Bioscience Ltd
10.11.1. Business Overview
10.11.2. Financial Snapshot
10.11.3. Products and Services Benchmarking
10.11.4. Recent Development
10.12. Promocell
10.12.1. Business Overview
10.12.2. Financial Snapshot
10.12.3. Products and Services Benchmarking
10.12.4. Recent Development
10.13. ALLCells
10.13.1. Business Overview
10.13.2. Financial Snapshot
10.13.3. Products and Services Benchmarking
10.13.4. Recent Development
10.14. Lonza Group, AG
10.14.1. Business Overview
10.14.2. Financial Snapshot
10.14.3. Products and Services Benchmarking
10.14.4. Recent Development
10.15. Creative Bioarray
10.15.1. Business Overview
10.15.2. Financial Snapshot
10.15.3. Products and Services Benchmarking
10.15.4. Recent Development
List of Tables
Table 1. Drivers and Inhibitors for Global Market
Table 2. Restraints Global Market
Table 3. Global Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 4. Global Primary Cells Market, by Animal Primary Cells, by Region, 2016-2028 (USD Million)
Table 5. Global Primary Cells Market, by Human Primary Cells, by Region, 2016-2028 (USD Million)
Table 6. Global Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 7. Global Primary Cells Market, by Hematopoietic, by Region, 2016-2028 (USD Million)
Table 8. Global Primary Cells Market, by Hepatocytes, by Region, 2016-2028 (USD Million)
Table 9. Global Primary Cells Market, by Renal Cells, by Region, 2016-2028 (USD Million)
Table 10. Global Primary Cells Market, by Gastrointestinal Cells, by Region, 2016-2028 (USD Million)
Table 11. Global Primary Cells Market, by Skin Cells, by Region, 2016-2028 (USD Million)
Table 12. Global Primary Cells Market, by Lung Cells, by Region, 2016-2028 (USD Million)
Table 13. Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
Table 14. Global Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 15. Global Primary Cells Market, by Medical, by Region, 2016-2028 (USD Million)
Table 16. Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, by Region, 2016-2028 (USD Million)
Table 17. Global Primary Cells Market, by Research Institutes, by Region, 2016-2028 (USD Million)
Table 18. Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
Table 19. Global Primary Cells Market, By Geography, 2016 - 2028 (USD Million)
Table 20. North America: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 21. North America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 22. North America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 23. North America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 24. U.S.: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 25. U.S.: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 26. U.S.: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 27. Canada: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 28. Canada: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 29. Canada: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 30. Europe: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 31. Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 32. Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 33. Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 34. Germany: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 35. Germany: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 36. Germany: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 37. UK: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 38. UK: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 39. UK: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 40. France: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 41. France: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 42. France: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 43. Italy: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 44. Italy: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 45. Italy: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 46. Spain: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 47. Spain: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 48. Spain: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 49. Rest of Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 50. Rest of Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 51. Rest of Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 52. Asia Pacific: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 53. Asia-Pacific: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 54. Asia-Pacific: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 55. Asia-Pacific: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 56. China: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 57. China: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 58. China: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 59. India: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 60. India: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 61. India: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 62. Japan: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 63. Japan: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 64. Japan: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 65. South Korea: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 66. South Korea: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 67. South Korea: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 68. Rest of APAC: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 69. Rest of APAC: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 70. Rest of APAC: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 71. Latin America: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 72. Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 73. Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 74. Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 75. Brazil: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 76. Brazil: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 77. Brazil: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 78. Mexico: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 79. Mexico: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 80. Mexico: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 81. Colombia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 82. Colombia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 83. Colombia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 84. Rest of Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 85. Rest of Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 86. Rest of Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 87. Middle East & Africa: Primary Cells Market, by Country, 2016-2028 (USD Million)
Table 88. Middle East & Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 89. Middle East & Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 90. Middle East & Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 91. Saudi Arabia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 92. Saudi Arabia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 93. Saudi Arabia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 94. South Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 95. South Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 96. South Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 97. Israel: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 98. Israel: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 99. Israel: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 100. UAE: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 101. UAE: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 102. UAE: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
Table 103. Rest of MEA: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
Table 104. Rest of MEA: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
Table 105. Rest of MEA: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
List of Figures
Figure 1. Market snapshot
Figure 2. Market segmentation & scope
Figure 3. Global Primary Cells market size and growth prospects, 2016 - 2028
Figure 4. Value chain analysis
Figure 5. Primary Cells market dynamics
Figure 6. Key market opportunities - prioritized
Figure 7. Industry analysis - Porter’s
Figure 8. PESTEL analysis
Figure 9. Global Primary Cells market share by Source, 2020 & 2028
Figure 10. Global Primary Cells market share by Type, 2020 & 2028
Figure 11. Global Primary Cells market share by End-User, 2020 & 2028
Figure 12. Global Primary Cells market share by Region, 2020 & 2028
Figure 13. Competitive environment
Figure 14. Strategy framework

Companies Mentioned

  • Cell Biologics Inc.
  • ZenBio Inc.
  • Stem Cell Technologies
  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • Cureline
  • American Type Culture Collection
  • Cell Applications Inc.
  • Pelobiotech
  • Merck KGaA
  • Axol Bioscience Ltd
  • Promocell
  • ALLCells
  • Lonza Group
  • AG
  • Creative Bioarray.

Related Topics

Related Reports

Primary Cells Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030 - Product Image

Primary Cells Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030

  • Report
  • Global
From
Primary Cell Culture Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030 - Product Image

Primary Cell Culture Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030

  • Report
  • Global
From
Global Primary Cells Market Trends and Forecasts - Product Image

Global Primary Cells Market Trends and Forecasts

  • Report
  • 108 Pages
  • Global
From
Primary Battery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 - Product Image

Primary Battery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • Report
  • 142 Pages
  • Global
From
Primary Battery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Image

Primary Battery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • 170 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.